causes not stated by the regulator — e.g. “El médico prescriptor deberá determinar la posibilidad de utilizar otros tratamientos comercializados.” (Spain)
Recent shortage history
Spain: resolved 26 Oct 2026 (began 22 Oct 2026)
Spain: resolved 26 Oct 2026 (began 12 Oct 2026)
Spain: resolved 26 Oct 2026 (began 20 Sept 2026)
Spain: resolved 27 Aug 2026 (began 6 Aug 2026)
Spain: resolved 6 Sept 2026 (began 4 Aug 2026)
Spain: resolved 6 Sept 2026 (began 8 Jul 2026)
Spain: resolved 19 Aug 2026 (began 28 Jun 2026)
Spain: resolved 30 Aug 2026 (began 14 Jun 2026)
Frequently asked questions
Is Levotiroxina Sodica Teva currently in shortage?
Yes. As of the latest regulator updates, Levotiroxina Sodica Teva has 2 active shortage notices across 1 country (Spain). Status is refreshed daily from official regulatory sources.
Why is Levotiroxina Sodica Teva in shortage?
Regulators attribute the current Levotiroxina Sodica Teva shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Levotiroxina Sodica Teva shortage be resolved?
Regulator-estimated resolution dates currently range from 19 Nov 2026 to 19 Nov 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Levotiroxina Sodica Teva shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Levotiroxina Sodica Teva status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.